AN ANALYSIS OF THE UTILIZATION OF CEPHALOSPORINS FROM 2007 TO 2011 IN GUANGDONG PROVINCE OF CHINA

Author(s)

Han S1, Guan X2, Wang T1, Shi L2, Li H2, Xin X1, Tian H1, Li H1
1Peking University, Beijing, China, 2International Research Center of Medicinal Administration, Peking University, Beijing, China

OBJECTIVES:  To analyze the relationship between the change of drug mix for Cephalosporins and their cost increases in order to provide a reference for future research and government policy making on cost of antacids and anti-ulcer medications. METHODS: Build a foundation based on drug DDD unit, analyze the index analysis system of the influence of drug mix of Cephalosporins on drug cost on different levels. RESULTS: The total procurement costs of Cephalosporins for Guangdong province and the purchases of DDD increased by 158% and 120% respectively in 2007-2011. At the same time, the price level declined significantly, the price index calculated by Laspeyres index decreased by 12%. CONCLUSIONS: The amount of drug utilization is the most important factor that caused cost increase, the decline of price inhibits the Cephalosporins drug price growth to a certain extent. Technological innovation is the motivating factor to cause the Cephalosporins drug price to increase. There is a link between the level index of administration route and the rationality of drug use. The competition among different manufacturers is an important factor that affects the total expenditure of Cephalosporins.

Conference/Value in Health Info

2014-09, ISPOR Asia Pacific 2014, Beijing, China

Value in Health, Vol. 17, No. 7 (November 2014)

Code

PIN32

Topic

Health Policy & Regulatory

Topic Subcategory

Pricing Policy & Schemes

Disease

Infectious Disease (non-vaccine)

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×